Inventor · disambiguated record
Bruce R. Blazar
Also filed as: BLAZAR BRUCE · BLAZAR BRUCE R · BLAZAR BRUCE ROBERT
27 granted patents·37 pending applications·272 citations·filing 1997–2025
96Inventor score
Top patents by PatentIndex Score
64 records- 0195US9393257B2TALEN-based gene correctionUNIV MINNESOTA·Filed 2014·Granted Jul 19, 2016·42 cites·10 claims
- 0293US8580249B2Cell therapy for the treatment of lysosomal storage disordersBLAZAR BRUCE·Filed 2011·Granted Nov 12, 2013·34 cites·18 claims
- 0391US6001329ARadiolabeled fusion toxins for cancer therapyUAB RESEARCH FOUNDATION·Filed 1997·Granted Dec 14, 1999·91 cites·11 claims
- 0490US7368106B2Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic stateUS HEALTH·Filed 2006·Granted May 6, 2008·7 cites·14 claims
- 0585US11311541B2Treatment of GVHDKADMON CORP LLC·Filed 2015·Granted Apr 26, 2022·4 cites·2 claims
- 0684US10874727B2Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2018·Granted Dec 29, 2020·1 cites·11 claims
- 0784US8129185B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesBLAZAR BRUCE·Filed 2009·Granted Mar 6, 2012·3 cites·2 claims
- 0884US7651855B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesUNIV PENNSYLVANIA·Filed 2004·Granted Jan 26, 2010·11 cites·14 claims
- 0984US6492498B1Multimeric immunotoxinsUNIV MINNESOTA·Filed 1999·Granted Dec 10, 2002·45 cites·28 claims
- 1083US7101542B1Cell-mediated targeting of toxins to pathogenic cellsVALLERA DANIEL A·Filed 2000·Granted Sep 5, 2006·11 cites·25 claims
- 1182US10172880B2Talen-based gene correctionUNIV MINNESOTA·Filed 2016·Granted Jan 8, 2019·3 cites·6 claims
- 1281US2024293409A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 1381US2024182854A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1480US9228172B2Inducible regulatory T-cell generation for hematopoietic transplantsRILEY JAMES L·Filed 2009·Granted Jan 5, 2016·2 cites·13 claims
- 1580US9181526B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesBLAZAR BRUCE·Filed 2012·Granted Nov 10, 2015·2 cites·14 claims
- 1679US2025288655A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1779US2025283040A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1877US8609412B2Mapc generation of lung tissuePANOSKALTSIS-MORTARI ANGELA·Filed 2005·Granted Dec 17, 2013·7 cites·4 claims
- 1976US2023100137A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 2072US10894061B2Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cellsUNIV MINNESOTA·Filed 2016·Granted Jan 19, 2021·1 cites·30 claims
- 2171US2020263131A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 2271US2021275650A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2371US2021187006A1Talen-based gene correctionUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 2470US10973844B2TALEN-based gene correctionUNIV MINNESOTA·Filed 2018·Granted Apr 13, 2021·0 cites·7 claims
- 2570US2025381188A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS LLC·Filed 2025·Application pending·0 cites
- 2668US2022395501A1Treatment of gvhdKADMON CORP LLC·Filed 2022·Application pending·0 cites
- 2768US2025281534A1Methods and compositions for improving immunotherapyUNIV MINNESOTA·Filed 2024·Application pending·0 cites
- 2867US2022348870A1Materials and methods for modifying the activity of t cellsUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 2967US2021177854A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 3065US12234480B2Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cellsUNIV MINNESOTA·Filed 2020·Granted Feb 25, 2025·0 cites·8 claims
- 3164US11471517B2Compositions and methods for preventing and treating graft versus host diseaseUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Oct 18, 2022·0 cites·8 claims
- 3261US11390848B2Materials and methods for modifying the activity of T cellsUNIV MINNESOTA·Filed 2017·Granted Jul 19, 2022·0 cites·5 claims
- 3361US2015157634A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 3460US7682796B2Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseasesKOZEL THOMAS R·Filed 2004·Granted Mar 23, 2010·7 cites·25 claims
- 3560US2013101567A1Methods to Expand a T Regulatory Cell Master Cell BankRILEY JAMES L·Filed 2011·Application pending·0 cites
- 3659US8192720B2Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseasesKOZEL THOMAS·Filed 2010·Granted Jun 5, 2012·1 cites·9 claims
- 3759US7175838B2Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic stateCHIRON CORP·Filed 2002·Granted Feb 13, 2007·0 cites·14 claims
- 3859US2018078558A1Methods of treating and preventing alloantibody driven chronic graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 3958US2009155311A1Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cellsMED COLLEGE OF GEORGIA RES INS·Filed 2007·Application pending·0 cites
- 4055US9435804B2Detection, prevention, and treatment of anthrax and other infectious diseasesBOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIV OF NEVADA·Filed 2013·Granted Sep 6, 2016·0 cites·13 claims
- 4154US2021322455A1Methods and compositions for increasing the suppressive function of regulatory t-cells (tregs)UNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 4254US2016151471A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV MINNESOTA·Filed 2015·Application pending·0 cites
- 4354US2003099622A1Systems and methods for inducing mixed chimerismUNIV MINNESOTA00000000·Filed 2002·Application pending·0 cites
- 4453US10993959B2Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)UNIV MINNESOTA·Filed 2016·Granted May 4, 2021·0 cites·16 claims
- 4553US2012142750A1Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cellsCHEN WEI·Filed 2011·Application pending·0 cites
- 4651US2002048579A1Ex vivo treatment of allogeneic and xenogeneic donor T-cells containing compositions (bone marrow) using gp39 antagonists and use thereofUNIV MINNESOTA·Filed 2001·Application pending·0 cites
- 4750US12270050B2Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and usingUNIV MINNESOTA·Filed 2016·Granted Apr 8, 2025·0 cites·18 claims
- 4848US2005208036A1Methods for treating or preventing GVHDUNIV NORTH CAROLINA·Filed 2005·Application pending·0 cites
- 4948US2004166095A1Methods for preventing GVHDFiled 2003·Application pending·0 cites
- 5048US2010055111A1Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cellsMED COLLEGE OF GEORGIA RES INS·Filed 2008·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →